Literature DB >> 19914739

Building a benchmark through active surveillance of intensive care unit-acquired infections: the Italian network SPIN-UTI.

A Agodi1, F Auxilia, M Barchitta, S Brusaferro, D D'Alessandro, M T Montagna, G B Orsi, C Pasquarella, V Torregrossa, C Suetens, I Mura.   

Abstract

The Italian Nosocomial Infections Surveillance in Intensive Care Units (ICUs) (SPIN-UTI) project of the Italian Study Group of Hospital Hygiene (GISIO - SItI) was undertaken to ensure standardisation of definitions, data collection and reporting procedures using the Hospital in Europe Link for Infection Control through Surveillance (HELICS)-ICU benchmark. Before starting surveillance, participant ICUs met in order to involve the key stakeholders in the project through participation in planning. Four electronic data forms for web-based data collection were designed. The six-month patient-based prospective survey was undertaken from November 2006 to May 2007, preceded by a one-month surveillance pilot study to assess the overall feasibility of the programme and to determine the time needed and resources for participant hospitals. The SPIN-UTI project included 49 ICUs, 3053 patients with length of stay >2 days and 35 498 patient-days. The cumulative incidence of infections was 19.8 per 100 patients and the incidence density was 17.1 per 1000 patient-days. The most frequently encountered infection type was pneumonia, Pseudomonas aeruginosa being the most frequent infection-associated micro-organism, followed by Staphylococcus aureus and Acinetobacter baumannii. Site-specific infection rates for pneumonia, bloodstream infections, central venous catheter-related bloodstream infections and urinary tract infections, stratified according to patient risk factors, were below the 75th centile reported by the HELICS network benchmark. The SPIN-UTI project showed that introduction of ongoing surveillance should be possible in many Italian hospitals. The study provided the opportunity to participate in the HELICS project using benchmark data for comparison and for better understanding of factors influencing risks. Copyright 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914739     DOI: 10.1016/j.jhin.2009.08.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  12 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI).

Authors: 
Journal:  J Prev Med Hyg       Date:  2019-10-15

Review 3.  Host stress and virulence expression in intestinal pathogens: development of therapeutic strategies using mice and C. elegans.

Authors:  Olga Zaborina; Alexander Zaborin; Kathleen Romanowski; Trissa Babrowski; John Alverdy
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Variations in identification of healthcare-associated infections.

Authors:  Sara C Keller; Darren R Linkin; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05-21       Impact factor: 3.254

5.  Quantitative evaluation of bacteria adherent and in biofilm on single-wall carbon nanotube-coated surfaces.

Authors:  Fabrizio Pantanella; Francesca Berlutti; Daniele Passeri; Daniela Sordi; Alessandra Frioni; Tiziana Natalizi; Maria Letizia Terranova; Marco Rossi; Piera Valenti
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-10-05

6.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

7.  Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells.

Authors:  Susan R Heimer; David J Evans; Michael E Stern; Joseph T Barbieri; Timothy Yahr; Suzanne M J Fleiszig
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

8.  Preventable proportion of intubation-associated pneumonia: Role of adherence to a care bundle.

Authors:  Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Emiliano Spera; Giovanni Gallo; Francesco Auxilia; Silvio Brusaferro; Marcello Mario D'Errico; Maria Teresa Montagna; Cesira Pasquarella; Stefano Tardivo; Ida Mura
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

9.  Epidemiology of blood stream infections at a level-1 trauma care center of India.

Authors:  Purva Mathur; Prince Varghese; Vibhor Tak; Jacinta Gunjiyal; Sanjeev Lalwani; Subodh Kumar; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2014-01

10.  Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013.

Authors:  Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Eugenia Aldisio; Anna Elisa Marchese; Anna Rita Mattaliano; Athanassios Tsakris
Journal:  Antimicrob Resist Infect Control       Date:  2015-11-03       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.